Resistant Microascus Cirrosus Pneumonia Can Be Treated with a Combination of Surgery, Multiple Anti-fungal Agents and a Growth Factor
Overview
Pharmacology
Affiliations
A 49-year old male with acute myelogenous leukemia relapsed eight years post allogeneic bone marrow transplantation. The patient received induction chemotherapy causing prolonged neutropenia. The patient developed pneumonia for which empirical antibacterial and antifungal therapy were started. The patient underwent a video-assisted thorocascopy with near complete resection of the lesion because of poor response to treatment. Microascus cirrosus was identified in the tissue. In vitro susceptibility test to different antifungal agents showed M. cirrosus was very resistant. The patient is undergoing second allogeneic transplant with improved pneumonia resulting from a combination of treatment for fungal infection, which included surgery, antifungal agents, and granulocyte-colony stimulating factor. The Microascus genus rarely causes invasive fungal infection in humans and can be very difficult to treat because of the resistance to available antifungal agents.
Cheng J, Zeng D, Zhang T, Zhang L, Han X, Zhou P Exp Ther Med. 2023; 26(2):404.
PMID: 37522054 PMC: 10375443. DOI: 10.3892/etm.2023.12103.
Li A, Liu B, Li F, He Y, Wang L, Kulyar M Front Microbiol. 2021; 12:712092.
PMID: 34475863 PMC: 8406688. DOI: 10.3389/fmicb.2021.712092.
Pulmonary infection in an immunocompetent patient with bronchiectasis: A case report.
Liu Q, Kong L, Hua L, Xu S Respir Med Case Rep. 2021; 34:101484.
PMID: 34386343 PMC: 8346684. DOI: 10.1016/j.rmcr.2021.101484.
Primary cutaneous infection due to Microascus cirrosus: a case report.
Gao L, Chen J, Gao D, Li M BMC Infect Dis. 2018; 18(1):604.
PMID: 30509190 PMC: 6276154. DOI: 10.1186/s12879-018-3535-5.
Invasive Scopulariopsis alboflavescens infection in patient with acute myeloid leukemia.
Kurata K, Nishimura S, Ichikawa H, Sakai R, Mizutani Y, Takenaka K Int J Hematol. 2018; 108(6):658-664.
PMID: 29987744 DOI: 10.1007/s12185-018-2496-1.